GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced plans to launch TOTAL30 ® for Astigmatism, the first-and-only ...

GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of PRECISION7®, the only one-week ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the U.S. launch of PRECISION7 ®, the only one-week ...

The first and only monthly Water Gradient multifocal contact lens that feels like nothing – even at day 301 Provides excellent visual acuity at all distances, near through far, with Alcon’s proven ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. NEW ORLEANS — Alcon introduced its recently launched ...

Please provide your email address to receive an email when new articles are posted on . Alcon announced plans to launch its Total30 for Astigmatism, a reusable, water-gradient contact lens, in the U.S ...

“We are making history with the bold innovation of PRECISION7,” said Max Wolf, General Manager, Head of Vision Care and Contact Lenses at Alcon. “Now, patients can start and end every week fresh with ...

Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: ...

Alcon is expected to outpace market growth and gain market share in the surgical and vision care sectors, with growth driven by factors such as the increasing global aging population and rise in ...

Company will pay $20 million as part of deal Alcon denies liability Trial set for March 28 for J&J Vision Care (Reuters) - Eye care device company Alcon Vision LLC on Thursday said it had agreed to ...

Oppenheimer has upgraded Alcon Inc (NYSE:ALC) following firm first-quarter earnings and several new drivers coming into view. The analyst sees a new opportunity in glaucoma with the announced ...